Gloucester Pharmaceuticals' Series D Round

Gloucester Pharmaceuticals raised a round of funding on August 11, 2009.

Gloucester Pharmaceuticals is developing a late-stage clinical compound for T-cell lymphomas and other malignancies.…

Articles about Gloucester Pharmaceuticals' Series D Round: